We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Gilead, Roche Sue To Block Generic Tamiflu

Law360 (March 15, 2011, 3:30 PM EDT) -- Gilead Sciences Inc. and Roche Holding Ltd. lodged a patent infringement suit Monday in Delaware in an effort to prevent Indian pharmaceutical company Natco Pharma Ltd. from marketing a generic version of the flu drug Tamiflu.

The case, filed in the U.S. District Court for the District of Delaware, alleges that Natco and a subsidiary infringed one of the plaintiffs' patents by submitting an abbreviated new drug application with the U.S. Food and Drug Administration.

“Plaintiffs institute this action to enforce their patent rights covering Tamiflu...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.